Expression of CCNE1 has been reported in various cancers such as bladder cancer [71], colorectal cancer [72], gastric [73], high-grade serous ovarian carcinomas (HGSCs) [74] and ovarian cancer [75]. Here, CCNE1 is linked to urinary bladder carcinoma.